Section Arrow
SXTC.NASDAQ
- China SXT Pharmaceuticals
(Financial Status)
Quotes are at least 15-min delayed:2025/02/23 10:27 EST
Last
 0.343
-0.0317 (-8.46%)
Day High 
0.4349 
Prev. Close
0.3747 
1-M High
0.474 
Volume 
1.56M 
Bid
0.3439
Ask
0.35
Day Low
0.34 
Open
0.39 
1-M Low
0.3659 
Market Cap 
1.52M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.38 
20-SMA 0.4 
50-SMA 0.41 
52-W High 3.37 
52-W Low 0.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.57/--
Enterprise Value
1.82M
Balance Sheet
Book Value Per Share
3.43
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.93M
Operating Revenue Per Share
0.49
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed:2025/02/23 10:27 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.